Joseph S. Bailes serves as Executive at Harpoon Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Joseph S. Bailes has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 11, 2024 involved selling 5,000 shares valued at $0.
Joseph S. Bailes currently holds 5,000 shares of Harpoon Therapeutics, Inc. (HARP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph S. Bailes has been a net neutral trader of HARP stock. They have purchased $0 and sold $0 worth of shares.
Joseph S. Bailes's most recent insider trade was on Mar 11, 2024, when they sold 5,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |